Delivery Order SPE2DX22D0010-SPE2D826FCD02
- Not listed
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with a ceiling value of $6,005.34 and an ultimate completion date of December 3, 2025. The contract does not carry a set-aside designation, and performance is based at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, issued on October 30, 2025, carries a ceiling value of $13,688.69 and is scheduled for completion by October 31, 2025. The award represents a non-competitive, non-set-aside transaction executed under an existing contract vehicle, reflecting the contractor's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed price delivery order, valued at $10,788.15 with completion targeted for December 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,119.13 to supply Nucynta ER (extended-release) 150mg tablets, with delivery expected by December 15, 2025. This firm fixed-price delivery order, awarded on December 12, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,005.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nucynta ER Tabs 100MG, a controlled-release opioid pain management pharmaceutical. The contract, awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical, under a firm fixed-price contract with a ceiling value of $4,442.48. The order was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025. This delivery order was not subject to a set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,982.00 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta Tabs 50mg, a prescription pain management pharmaceutical. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Nucynta ER 100 mg tablets in quantities of 60 units. This is a firm fixed price delivery order valued at $4,275.36 with an ultimate completion date of December 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCD02Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order has a ceiling value of $10,219.87 and an ultimate completion date of January 5, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects DLA's strategy of utilizing prime vendor contracts to efficiently distribute essential medications and medical commodities across the Defense Health Agency and other federal healthcare systems.